If the 2018 paper showed the trial is a success, then why haven't they submitted a BLA and where is FDA approval as we are about to enter 2022? If the data showed success in 2018, then why didn't they stop the trial then and begin the process to certain approval? If the data was so good then why did they keep the trial going? Something doesn't add up with your argument, and the reason is because it's all a lie. They paid to have that junk paper published in that third-rate journal because no credible journal would accept it. You do know that right?
Companies don't sit on positive data. No company in history has ever sat on positive data. Never. It's just stupid to suggest a company would. NWBO does not have positive data, and that is why they are refusing to release it 15 months past data lock and unblinding. It's all a lie and shareholders are being scammed. The excuse about waiting for yet another journal so they can release the data the right way is just laughable. It has zero credibility because, again, companies don't sit on positive data. And we are now 15 months past data lock so where is the journal article? This is so absurd, and no one with any common sense at all is buying it anymore.
They've got their Sawston certification, so now they can either bury the failed trial in a regulatory filing or just not release it at all. Now they move toward developing their manufacturing operation and figuring out how they will cut NWBO shareholders out of the profits, which will likely involve Advent or a third party buying the property. She has done this before, so we know what is going to happen. Don't believe what people say, believe what they do. She did this before with Cognate and she is going to do it again. You all know this is true, and yet you still prefer to believe in fantasies. I've been telling you this is a scam for three years now.
